diabetes. Type 2 diabetes mellitus
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Uncontrolled type 2 diabetes Age 30-65 years HbA1c greater than 7 and lower than 8.5 Under treatment with oral diabetes medications (one or more drug groups) At least one month after increasing the dose of antidiabetic medicine or prescribing a new antidiabetic medicine
Exclusion criteria
Exclusion criteria: Glomerular filtration rate, lower than 60 ml per minute Serum albumin, lower than 4 g/dL SGOT and SGPT, three times higher than normal level Pregnancy and breastfeeding or intention to become pregnant Taking insulin along with oral diabetes medications
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Blood sugar. Timepoint: Blood sugar measurement at the beginning of the study (before the start of the intervention) and three months after taking the Tabashir capsule. Method of measurement: Blood test. | — |
Secondary
| Measure | Time frame |
|---|---|
| Lipid profile. Timepoint: At the beginning and end of three months of study. Method of measurement: Blood test. | — |
Countries
Iran (Islamic Republic of)
Contacts
Shahed University